Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
78.78
+1.38 (1.78%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Haemonetics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Haemonetics stock has a consensus rating of "Buy" and an average price target of $86.6. The average 1-year stock price forecast is 9.93% higher than the current stock price, while the lowest is $62 (-21.30%) and the highest is $104 (+32.01%).
Price Target: $86.6 (+9.93%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $85 → $90 | Buy | Maintains | $85 → $90 | +14.24% | Jul 15, 2026 |
| Raymond James | Raymond James | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 14, 2026 |
| Citi | Citi | Hold Maintains $70 → $79 | Hold | Maintains | $70 → $79 | +0.28% | Jul 8, 2026 |
| BTIG | BTIG | Buy Reiterates $84 | Buy | Reiterates | $84 | +6.63% | Jun 26, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $80 | Buy | Maintains | $80 | +1.55% | Jun 5, 2026 |
Financial Forecast
Revenue This Year
1.40B
from 1.33B
Increased by 5.08%
Revenue Next Year
1.47B
from 1.40B
Increased by 5.16%
EPS This Year
5.22
from 4.96
Increased by 5.19%
EPS Next Year
5.63
from 5.22
Increased by 7.84%
EPS and Forward PE are based on non-GAAP adjusted numbers.